Since its inception in 2018 as the Cure SURF1 Foundation, Cure Mito has devoted significant resources to the development of a gene therapy for the treatment of SURF1 Leigh syndrome. Here we provide a plain-language description of the science behind this approach, as well as the history of its development, and current progress. Learn more in our new blog post: Developing a SURF-1 Gene Therapy – Cure Mito Foundation
